”Metaling” with new stent designs

A. Carter,David P. Lee,A. Yeung

DOI: https://doi.org/10.1002/ccd.1195

IF: 2.3

2001-07-01

Catheterization and Cardiovascular Interventions

Abstract:During the last decade, a coalescence of design, engineering, and manufacturing of contemporary stents together with refined clinical techniques has transformed the practice of interventional cardiology into the stentors domain [1]. A massive body of medical literature, intellectual property, and commercialization of over 50 stent designs documents the impact of this medical device and our zest to develop the ultimate stent. In the United States, several low-profile, flexible, balloon-expandable stainless steel stents are FDA-approved for abrupt or threatened closure and the prevention of postangioplasty restenosis. These contemporary stent designs are manufactured from stainless steel tubes or shaped from wires to form openor closed-cell tubular structures ranging from 8 to 38 mm in length. In vitro and in vivo testing has documented differences in longitudinal flexibility, scaffolding properties, and recoil of the stents commercially available in the United States. Preclinical studies and clinical trials have also demonstrated improved biocompatibility for these later-generation stents as compared with the first-generation tubular (Palmaz-Schatz, Jonhson and Johnson) or coil (Gianturco-Roubin, Cook) designs [2–7]. The later-generation tubular (MULTI-LINK, Guidant; NIR, Medinol; Bx Velocity, Cordis) and coil (S670, Medtronic) stents can be easily delivered to most anatomic locations and in a variety of lesion subsets with a greater than 98% likelihood of angiographic success [1]. Subacute thrombosis and restenosis occurs with a similar and surprisingly low frequency for each of the contemporary stent designs, although randomized clinical trials are not available to support this conclusion. The widespread clinical success of these stent platforms provides the impression of a plateau with engineering and design of the endovascular prosthesis. In the present issue, preclinical data published by Taylor et al. [8] conforms to the current paradigm of stent design. The authors documented bioequivalence at 28 days in a porcine coronary model for three stainless steel balloon-expandable stents deployed at low inflation pressures (8 atm) and a unique nitinol self-expanding stent. Quantitative and qualitative histological assessment including vessel morphometry, injury, cellular proliferation, and collagen deposition were employed to document the biological response to the prosthesis. The histological parameters were similar for each of the balloon-expandable stainless steel tubular designs while the chronic expansion forces of the nitinol stents caused increased neointimal formation, principally excess matrix tissue, proportional to the degree of progressive stent enlargement. The balloon-expandable stents evaluated in the present study have substantially different structures and expansion characteristics known to impact on acute and chronic mechanical arterial injury, inflammation, and neointimal formation. Previous preclinical studies and a randomized multicenter clinical trial support the impact of stent geometry on uniformity of expansion and vessel wall interactions that promotes a more favorable biological response. In the present study, the authors report a trend for more neointimal formation with the first-generation tubular-slotted Palmaz-Schatz stent as compared with the later-generation corrugated-ring and closed-cell tubular designs. These data are consistent with more compelling published reports that have demonstrated increased vessel injury, inflammation, and neointimal formation with the Palmaz-Schatz stent when deployed at inflation pressures typical for clinical application of coronary stents [2,5]. The less dramatic impact of stent design observed in the present study likely reflects a difference in expansion force-dependent conformational changes for the tubular-slotted stent, such as strut twisting and nonuniform expansion of the substructural elements encountered with high-pressure dilation required for clinical applications. These conformational changes in stent structure are more likely to induce endothelial denudation, arterial injury, and provides a nonuniform luminal surface that promotes platelet deposition, inflammatory cell adhesion each contributing to enhanced neointimal formation [9]. The later-generation designs such as the MULTI-LINK and Bx Velocity each incorporates design elements that allows uniform stent expansion at deployment pressures less than 9 atm using material similar to the Palmaz-Schatz stent. Indeed, a vast body of literature supports the advantages of these contemporary Catheterization and Cardiovascular Interventions 53:426–428 (2001)